Work

Vandetanib (ZD6474), a novel multitargeted kinase inhibitor, in cancer therapy

Year: 2006

Type: article

Source: Drugs of today

DOI: 10.1358/dot.2006.42.10.1025318

Authors: Sahtornsumetee, S., Rich, J.N.

Institutions: Duke University, Duke Medical Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2052796007

FWCI: 0.738

Cites:

Cited by: 29

Related to: 10